Golidocitinib Capsules are primarily indicated for the treatment of relapsed or refractory peripheral T-cell lymphoma. Its current market price is approximately 2,215 US dollars per box (specification: 0.15g × 30 capsules). This significant price reduction has been achieved thanks to the implementation of medical insurance reimbursement policies, which has markedly lightened the burden of medical expenses on patients.
I. Price Details
Current Price
It is priced at around 2,215 US dollars per box (containing 30 capsules) for the standard specification of 0.15g per capsule.
Original Price Comparison
Prior to its inclusion in the national medical insurance catalog, the price was as high as about 4,885 US dollars per box. With medical insurance coverage, the price has dropped by more than 50%.
Specification Notes
The drug is available in capsule form, with 30 capsules per box, manufactured by licensed pharmaceutical enterprises. Note that the actual price may vary slightly depending on local or hospital policies.
II. Impacts of Medical Insurance Policies
Effect of Medical Insurance
Since the implementation of the updated 2025 national medical insurance catalog, this drug has been included in the scope of medical insurance reimbursement, leading to a substantial reduction in patients' out-of-pocket expenses.
Reimbursement Process
Patients are required to obtain a prescription under the guidance of a physician and settle the payment through the medical insurance system. The actual out-of-pocket amount is subject to the local reimbursement rate and the individual’s type of medical insurance coverage.
III. Other Key Considerations
Indications for Use
Golidocitinib Capsules are only indicated for adult patients with relapsed or refractory peripheral T-cell lymphoma who have received at least one line of prior therapy, and must be used in strict accordance with the physician’s instructions.
Purchasing Recommendations
It is recommended to obtain the drug from authorized hospitals or pharmacies. Patients are advised to consult the detailed rules for medical insurance reimbursement in advance to avoid additional costs arising from unauthorized channels or misleading information.
